ClinicalTrials.Veeva

Menu

Cardiac Autonomic Dysfunction As a Sign of Irreversible Advanced Heart Failure (CADYSH)

U

University Hospital Bispebjerg and Frederiksberg

Status

Enrolling

Conditions

Heart Failure

Treatments

Diagnostic Test: heart monitoring

Study type

Observational

Funder types

Other

Identifiers

NCT06532825
H-24002374

Details and patient eligibility

About

The main hypothesis is that autonomic dysfunction cannot improve among patients reaching end-stage heart failure. To evaluate this, patients admitted with acute decompensated heart failure in Bispebjerg hospital, and history one or more admissions with the same condition within the prior year, will undergo repeated brief heart monitoring (10 min). Baseline recordings (at admission) will be compared with equivalent measurements before discharge to explore whether heart rate variability increases. Patients will be followed for six months after discharge from the hospital.

Full description

If the patient accepts to participate and signed the project informed consent, their clinical record will be followed until the last patient included has been followed for six months.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18-years age or older
  • admitted with acute decompensated heart failure for less than 48 h

Exclusion criteria

  • pacemaker
  • not signed informed consent
  • other heart rhythm than sinus rhythm or atrial fibrillation

Trial contacts and locations

1

Loading...

Central trial contact

Helena Dominguez

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems